{{Rsnum
|rsid=12583006
|Gene=TNFSF13B
|Chromosome=13
|position=108285104
|Orientation=plus
|GMAF=0.2769
|Gene_s=TNFSF13B
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 5.3 | 37.2 | 57.5
| HCB | 19.0 | 47.4 | 33.6
| JPT | 25.7 | 49.6 | 24.8
| YRI | 0.7 | 14.3 | 85.0
| ASW | 1.8 | 17.5 | 80.7
| CHB | 19.0 | 47.4 | 33.6
| CHD | 17.4 | 55.0 | 27.5
| GIH | 5.9 | 40.6 | 53.5
| LWK | 0.0 | 12.7 | 87.3
| MEX | 31.0 | 43.1 | 25.9
| MKK | 1.3 | 23.7 | 75.0
| TSI | 6.9 | 34.3 | 58.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=23845207
|Title=B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome
}}

{{PMID Auto
|PMID=19051265
|Title=Serum BLyS levels increase after rituximab as initial therapy in patients with follicular Grade 1 non-Hodgkin lymphoma.
|OA=1
}}

{{PMID Auto
|PMID=19383901
|Title=Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma.
|OA=1
}}

{{on chip | Affy GenomeWide 6}}